Find all School-related info fast with the new School-Specific MBA Forum

It is currently 24 Oct 2014, 07:55

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

The Pharmaceutical industry argues that because new drugs

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
Manager
Manager
avatar
Joined: 29 Aug 2007
Posts: 111
Followers: 1

Kudos [?]: 2 [0], given: 0

The Pharmaceutical industry argues that because new drugs [#permalink] New post 29 Aug 2007, 19:01
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 0% (00:00) wrong based on 0 sessions
The Pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years protection provided by patents should be extended in case of newly developed drugs. However, other industries new product development continues despite high devlp costs, a fact that indicates, extension is unnecessary

Which of the following if true, most strongly supports the pharmaceutical industry's arguement against the challenge made

1. No industry other than pharmaceutical industry have asked for an extnsion on the 20 yr limit

2. clinical trials of new durgs which occur after the patent is granted and before the new drug can be markated , often take 10 years to complete..

3. there are several industraties n which ration of research and develop is higher than pharm industry

4. an existing patent for a drug does not legally prevent pharm companies form bringing to market alternative drugs

5. Much recent industrial innovation has occurred in products for eg, in the computer and electronics industries for which the patent protection is often very ineffective

oA to be psoted later.
Manager
Manager
User avatar
Joined: 23 Jul 2007
Posts: 197
Followers: 1

Kudos [?]: 6 [0], given: 0

 [#permalink] New post 29 Aug 2007, 19:13
Not a very solid question but choice 2 is the only available choice here.
Manager
Manager
avatar
Joined: 18 Aug 2007
Posts: 75
Followers: 1

Kudos [?]: 1 [0], given: 0

 [#permalink] New post 30 Aug 2007, 04:26
This one boils down to B and E.

I would pick E since this supports the argument more strongly than B does.

If the patent protection is ineffective for the other industries, they would not feel the need to extend the protection period. Hence, it softens the reasoning given in the question against pharma companies.

B on the other hand talks only about Pharma Industries. We do not have any information about other indus. to say that it strengthens the argument.
VP
VP
avatar
Joined: 10 Jun 2007
Posts: 1467
Followers: 6

Kudos [?]: 108 [0], given: 0

Re: CR - Good one [#permalink] New post 30 Aug 2007, 05:27
beatgmat wrote:
The Pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years protection provided by patents should be extended in case of newly developed drugs. However, other industries new product development continues despite high devlp costs, a fact that indicates, extension is unnecessary

Which of the following if true, most strongly supports the pharmaceutical industry's arguement against the challenge made

1. No industry other than pharmaceutical industry have asked for an extnsion on the 20 yr limit

2. clinical trials of new durgs which occur after the patent is granted and before the new drug can be markated , often take 10 years to complete..

3. there are several industraties n which ration of research and develop is higher than pharm industry

4. an existing patent for a drug does not legally prevent pharm companies form bringing to market alternative drugs

5. Much recent industrial innovation has occurred in products for eg, in the computer and electronics industries for which the patent protection is often very ineffective

oA to be psoted later.


B
Only B makes sense.
Manager
Manager
User avatar
Joined: 23 Jul 2007
Posts: 197
Followers: 1

Kudos [?]: 6 [0], given: 0

 [#permalink] New post 01 Sep 2007, 00:38
OA please?
Manager
Manager
avatar
Joined: 20 Dec 2004
Posts: 181
Followers: 2

Kudos [?]: 13 [0], given: 0

 [#permalink] New post 01 Sep 2007, 01:06
I will go with B as well since this choice explains clearly why in pharmaceutical industry patents need to be extended. If after a patent has been approved, clinical trials consume upto 10 years during which period it cannot be marketed then pharmaceutical industries get very little time to take advantage of the patent. The converse need not be proved since it is given that other industries continue to manufacture.

I have to admit that E is attractive too. What's the OA
_________________

Regards

Subhen

Manager
Manager
User avatar
Joined: 23 Jul 2007
Posts: 197
Followers: 1

Kudos [?]: 6 [0], given: 0

 [#permalink] New post 01 Sep 2007, 01:14
  [#permalink] 01 Sep 2007, 01:14
    Similar topics Author Replies Last post
Similar
Topics:
The pharmaceutical industry argues that because new drugs tracyyahoo 9 02 Aug 2011, 06:53
1 Experts publish their posts in the topic The automobile industry in Country A argues that, because maddy2u 18 24 Dec 2010, 09:35
Pharmaceutical Industry allbusiness 1 16 Aug 2010, 08:39
The pharmaceutical industry argues that because new drugs noboru 18 24 May 2010, 15:32
The pharmaceutical industry argues that because new drugs Taku 10 21 Mar 2005, 00:37
Display posts from previous: Sort by

The Pharmaceutical industry argues that because new drugs

  Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.